Adialante: Funding, Investors & Team (Sep 2026)
Adialante develops deployable, clinical-grade MRI systems designed to reduce the cost and footprint of traditional scanners. The company focuses on a novel B1 encoding architecture that minimizes or removes B0 gradient coils to enable quieter, portable neuroimaging. Its platform targets cancer and brain screening in clinics and communities that lack conventional MRI infrastructure. Adialante also offers workshops, innovation courses, and consultation services related to clinical partnerships and healthcare technology development. Customers include healthcare providers, clinics, and research organizations seeking accessible MRI solutions.
Adialante has raised $500k across 1 funding round on record, the most recent a Pre-Seed of $500k announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Adialante Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Adialante Funding Rounds
Adialante Founders and Leadership Team
No contact details are on record for this team yet.
Adialante Funding Compared to Other Biotechnology Startups
Adialante's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Adialante in Biotechnology and Minneapolis
Companies Similar to Adialante
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Adialante Funding FAQs
What does Adialante do?
Adialante develops deployable, clinical-grade MRI systems designed to reduce the cost and footprint of traditional scanners. The company focuses on a novel B1 encoding architecture that minimizes or removes B0 gradient coils to enable quieter, portable neuroimaging. Its platform targets cancer and brain screening in clinics and communities that lack conventional MRI infrastructure. Adialante also offers workshops, innovation courses, and consultation services related to clinical partnerships and healthcare technology development. Customers include healthcare providers, clinics, and research organizations seeking accessible MRI solutions.
How much funding has Adialante raised?
Adialante has raised $500k across 1 round on record. The most recent is a Pre-Seed of $500k announced in Jun 2026.
When did Adialante last raise funding?
Adialante's most recent funding round on record is a Pre-Seed of $500k, announced in Jun 2026.
Who founded Adialante?
FundedIQ lists Efrain Torres (Founder) at Adialante.
Where is Adialante headquartered?
Adialante is based in Minneapolis, Minnesota, United States.
How many employees does Adialante have?
Adialante is in the 1-10 employee band.
How does Adialante's funding compare to other Biotechnology startups?
Adialante's latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Adialante Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adialante is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.